Most cited papers in Breast Cancer Treatment Studies

Breast Cancer Treatment Studies

What are the most cited papers in Breast Cancer Treatment Studies?

The most cited paper in Breast Cancer Treatment Studies is "New Guidelines to Evaluate the Response to Treatment in Solid Tumors" (Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al., 2000), with 15,773 citations. Next come "Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer" (13,212) and "Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2" (11,628).

Published TypeAccessAuthorsCitations

Showing 50 of 100 papers. Every paper with more than 1,895 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute	2 Feb 2000	15,773
2	Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology Open access	2013	13,212
3	Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 Dennis J. Slamon, Brian R Leyland-Jones, Steven Shak et al. · New England Journal of Medicine Open access	15 Mar 2001	11,628
4	Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Thérese Sørlie, Charles M. Perou, Robert John Tibshirani et al. · Proceedings of the National Academy of Sciences Open access	11 Sep 2001	11,073
5	Gene expression profiling predicts clinical outcome of breast cancer Laura van ‘t Veer, Hongyue A. Dai, Marc J. van de Vijver et al. · Nature Open access	2002	9,661
6	The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging Mahul B. Amin, Frederick L. Greene, Stephen B. Edge et al. · CA A Cancer Journal for Clinicians Open access	17 Jan 2017	6,689
7	A Gene-Expression Signature as a Predictor of Survival in Breast Cancer Marc J. van de Vijver et al. · New England Journal of Medicine Open access	18 Dec 2002	6,562
8	A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer Soonmyung Paik, Steven Shak, Gong Tang et al. · New England Journal of Medicine Open access	10 Dec 2004	6,414
9	Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer Bernard Fisher, Stewart Anderson, John Bryant et al. · New England Journal of Medicine Open access	16 Oct 2002	6,293
10	pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up C.W. Elston, Ian Ogilvie Ellis · Histopathology	Nov 1991	6,254
11	Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Bernard Fisher, Joseph P. Costantino, Donald Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute Open access	16 Sep 1998	5,532
12	Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer Edward H. Romond et al. · New England Journal of Medicine Open access	20 Oct 2005	5,398
13	Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence Rebecca Alexandra Dent, Maureen Trudeau, Kathleen I. Pritchard et al. · Clinical Cancer Research Open access	Aug 2007	5,223
14	Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Mike J Clarke · The Lancet	Dec 2005	5,167
15	Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Martine J Piccart et al. · New England Journal of Medicine Open access	20 Oct 2005	5,138
16	Breast Cancer Treatment Adrienne Gropper Waks, Eric P. Winer · JAMA	22 Jan 2019	5,015
17	Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes Joel S. Parker, Michael Eugene Mullins, Maggie C.U. Cheang et al. · Journal of Clinical Oncology Open access	9 Feb 2009	4,974
18	Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Patricia Cortazar et al. · The Lancet Open access	13 Feb 2014	4,858
19	Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer Massimo Cristofanilli, George Thomas Budd, Matthew J. Ellis et al. · New England Journal of Medicine Open access	18 Aug 2004	4,641
20	American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Antonio C. Wolff et al. · Journal of Clinical Oncology Open access	12 Dec 2006	4,487
21	Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer Umberto Veronesi, Natale Cascinelli, Luigi Mariani et al. · New England Journal of Medicine Open access	16 Oct 2002	4,479
22	Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer Peter Schmid, Sylvia Adams, Hope S. Rugo et al. · New England Journal of Medicine Open access	20 Oct 2018	4,469
23	Ki67 expression in breast cancer Mohamed A. Elkablawy, Abdulkader Mohammed Albasri, Rabab Mohammed et al. · Saudi Medical Journal Open access	Feb 2016	4,397
24	An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients Balázs Győrffy, András Lánczky, Aron Charles Eklund et al. · Breast Cancer Research and Treatment	17 Dec 2009	4,380
25	American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer M. Elizabeth H. Hammond et al. · Journal of Clinical Oncology Open access	19 Apr 2010	4,301
26	Triple-Negative Breast Cancer William David Foulkes, Ian E. Smith, Jorge Sergio Reis-Filho · New England Journal of Medicine	10 Nov 2010	4,277
27	Tamoxifen for early breast cancer: an overview of the randomised trials Abe, Osahiko, Bartholomeus, Sylvie, Piccart-Gebhart, Martine · The Lancet	May 1998	4,118
28	Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology	7 Oct 2013	4,103
29	Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer Sarah C. Darby, Marianne Ewertz, Paul McGale et al. · New England Journal of Medicine Open access	13 Mar 2013	4,034
30	Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials S Darby, Paul McGale, Candace R. Correa et al. · The Lancet ReviewOpen access	22 Oct 2011	4,007
31	Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Aron Goldhirsch, W. C. Wood, Alan Stuart Coates et al. · Annals of Oncology Open access	28 Jun 2011	3,932
32	Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study Lisa A. Carey, Charles M. Perou, Chad Livasy et al. · JAMA	6 Jun 2006	3,866
33	Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer Sunil Verma, David W. Miles, Luca Gianni et al. · New England Journal of Medicine Open access	Oct 2012	3,859
34	Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch et al. · Annals of Oncology Open access	6 Aug 2013	3,776
35	Nomograms in oncology: more than meets the eye Vinod P. Balachandran, Mithat Gönen, Jesse Joshua Smith et al. · The Lancet Oncology Open access	29 Mar 2015	3,518
36	Current and future burden of breast cancer: Global statistics for 2020 and 2040 Melina Arnold, Eileen Morgan, Harriet Rumgay et al. · The Breast Open access	2 Sep 2022	3,413
37	Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer Babak Ehteshami Bejnordi et al. · JAMA Open access	12 Dec 2017	3,405
38	Pembrolizumab for Early Triple-Negative Breast Cancer Peter Schmid et al. · New England Journal of Medicine Open access	26 Feb 2020	3,298
39	Breast cancer statistics, 2019 Carol E. Desantis, Jiemin Ma, Mia M. Gaudet et al. · CA A Cancer Journal for Clinicians Open access	2 Oct 2019	3,240
40	Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Early Breast Cancer Trialists' Collaborative Group (EBCTCG) · The Lancet ReviewOpen access	Aug 2011	3,114
41	Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine Open access	26 Dec 2007	3,085
42	Palbociclib and Letrozole in Advanced Breast Cancer Richard S. Finn, Miguel Martín, Hope S. Rugo et al. · New England Journal of Medicine	16 Nov 2016	3,059
43	Breast cancer Nadia Harbeck, Frederique Madeleine Penault-Llorca, Javier Cortés et al. · Nature Reviews Disease Primers ReviewOpen access	23 Sep 2019	3,056
44	Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano · JAMA Open access	8 Feb 2011	2,968
45	Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers Karoline B. Kuchenbaecker et al. · JAMA Open access	20 Jun 2017	2,963
46	Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess et al. · Journal of Clinical Oncology Open access	4 Feb 2008	2,948
47	Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer Armando E. Giuliano, Daniel M. Kirgan, Julia Guenther et al. · Annals of Surgery Open access	Sep 1994	2,923
48	Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Stefan Paul Aebi, T. Davidson, Günther Gruber et al. · Annals of Oncology Open access	May 2010	2,861
49	Adjuvant Trastuzumab in HER2-Positive Breast Cancer Dennis J. Slamon et al. · New England Journal of Medicine Open access	5 Oct 2011	2,803
50	Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yixin Wang, Jan G.M. Klijn, Yi Zhang et al. · The Lancet	Feb 2005	2,723

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.